Synonyms: | |
Status: | Phase 3 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | 3YN0602W4W |
InChI Key | PKXWXXPNHIWQHW-RCBQFDQVSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C19H27N3O4 |
Molecular Weight | 361.44 |
AlogP | 0.38 |
Hydrogen Bond Acceptor | 4.0 |
Hydrogen Bond Donor | 3.0 |
Number of Rotational Bond | 5.0 |
Polar Surface Area | 98.74 |
Molecular species | NEUTRAL |
Aromatic Rings | 1.0 |
Heavy Atoms | 26.0 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Gamma-secretase inhibitor | PubMed |
Primary Target | |
---|---|
presenilin 1 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Protease
Aspartic protease
Aspartic protease AD clan
Aspartic protease A22A subfamily
Aspartic protease A22A regulatory subfamily
|
126 | 3-200 | - | - | - | |
Enzyme
|
126 | 3-200 | - | - | - | |
Ion channel
Other ion channel
Miscellaneous ion channel
Presenilin ER Ca2+ leak channel family
|
126 | 3-200 | - | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Alzheimer Disease | 3 | D000544 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 425386-60-3 |
ChEBI | 131158 |
ChEMBL | CHEMBL520733 |
DrugBank | DB12463 |
EPA CompTox | DTXSID10235740 |
FDA SRS | 3YN0602W4W |
Guide to Pharmacology | 6978 |
PDB | ESF |
PubChem | 9843750 |
SureChEMBL | SCHEMBL417581 |
ZINC | ZINC000003989041 |